dc.contributor.author
Olson, Ashley D.
dc.contributor.author
Guiguet, Marguerite
dc.contributor.author
Zangerle, Robert
dc.contributor.author
Gill, John
dc.contributor.author
Pérez-Hoyos, Santiago
dc.contributor.author
Lodi, Sara
dc.contributor.author
Ghosn, Jade
dc.contributor.author
Dorrucci, Maria
dc.contributor.author
Johnson, Anne
dc.contributor.author
Sannes, Mette
dc.contributor.author
Moreno, Santiago
dc.contributor.author
Porter, Kholoud
dc.contributor.author
Universitat Autònoma de Barcelona
dc.identifier
https://ddd.uab.cat/record/185046
dc.identifier
urn:10.1097/QAI.0000000000000240
dc.identifier
urn:oai:ddd.uab.cat:185046
dc.identifier
urn:pmid:24872130
dc.identifier
urn:pmcid:PMC4134321
dc.identifier
urn:pmc-uid:4134321
dc.identifier
urn:articleid:19447884v67p15
dc.identifier
urn:scopus_id:84906088923
dc.identifier
urn:wos_id:000340727600007
dc.identifier
urn:altmetric_id:2386650
dc.identifier
urn:oai:pubmedcentral.nih.gov:4134321
dc.description.abstract
Supplemental Digital Content is Available in the Text. Rapid CD4 cell loss represents an HIV phenotype used to identify causal variants of accelerated disease progression. The optimal rate and threshold for identifying this extreme phenotype in recently infected individuals is unclear. Using a cohort of patients with known dates of HIV-1 seroconversion (SC), CASCADE (Concerted Action on SeroConversion on AIDS and Death in Europe), we identified proportions experiencing nadir CD4 cell levels within 1 year of SC, and assessed their mean AIDS-free survival time at 10-year follow-up and hazard of AIDS/death, compared with those whose CD4 remained.
dc.format
application/pdf
dc.relation
European Commission 260694
dc.relation
Journal of acquired immune deficiency syndromes (1999) ; Vol. 67, Issue 1 (September 2014), p. 15-21
dc.rights
Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
dc.rights
https://creativecommons.org/licenses/by/3.0/
dc.subject
Rare phenotype
dc.subject
Disease progression
dc.title
Evaluation of Rapid Progressors in HIV Infection as an Extreme Phenotype